<i>RASA1</i>Mutations and Associated Phenotypes in 68 Families with Capillary Malformation-Arteriovenous Malformation

Nicole Revençu(de Duve Institute), Laurence M. Boon(de Duve Institute), Antonella Mendola(de Duve Institute), Maria Cordisco(Garrahan Hospital), Josée Dubois(Centre Hospitalier Universitaire Sainte-Justine), Philippe Clapuyt(Cliniques Universitaires Saint-Luc), Frank Hammer(Cliniques Universitaires Saint-Luc), David J. Amor(Victorian Clinical Genetics Services), Alan D. Irvine(Our Lady's Hospital), Eulàlia Baselga(Hospital de Sant Pau), A. Dompmartin(Centre Hospitalier Universitaire de Caen), Samira Syed(University College London), A. Martín‐Santiago(Hospital Universitario Son Espases), Lesley C. Adès(Children's Hospital at Westmead), Felicity Collins(Children's Hospital at Westmead), Janine Smith(Children's Hospital at Westmead), Sarah A. Sandaradura(Children's Hospital at Westmead), Victoria R. Barrio(Rady Children's Hospital-San Diego), Patricia E. Burrows(Roosevelt Hospital), Francine Blei(Theodore Roosevelt High School), Mariarosaria Cozzolino(University of Naples Federico II), Nicola Brunetti‐Pierri(University of Naples Federico II), Asunción Vicente(Hospital Sant Joan de Déu Barcelona), Marc Abramowicz(Université Libre de Bruxelles), Julie Désir(Erasmus Hospital), Catheline Vilain(Université Libre de Bruxelles), Wendy K. Chung(Columbia University), Ashley Wilson(Morgan Stanley Children's Hospital), Carol Gardiner(University of Nottingham), Yim Dwight(Kaiser Permanente Moanalua Medical Center), David Lord(Children's Hospital at Westmead), Leona Fishman(Hospital for Sick Children), Cheryl Cytrynbaum(Hospital for Sick Children), Sarah L. Chamlin(Lurie Children's Hospital), Fred Ghali(Agile Mind), Yolanda Gilaberte(Hospital General San Jorge), Shelagh Joss(Southern General Hospital), María del Carmen Boente, C. Léauté‐Labrèze(Centre Hospitalier Universitaire de Bordeaux), Marie-Ange Delrue(Centre Hospitalier Universitaire de Bordeaux), Susan Bayliss(St. Louis Children's Hospital), Loreto Martorell(Hospital Sant Joan de Déu Barcelona), Maria-Antonia González-Enseñat(Hospital Sant Joan de Déu Barcelona), J. Mazereeuw‐Hautier(Hôpital Larrey), Brid O’Donnell(Temple Street Children's University Hospital), D. Bessis(Hôpital Saint Eloi), Reed E. Pyeritz(University of Pennsylvania), Aïcha Salhi(Centre de Recherche Nucléaire d’Alger), Oon Tian Tan(Harvard University), Orli Wargon(Sydney Children's Hospital), John B. Mulliken(Boston Children's Hospital), Miikka Vikkula(Cliniques Universitaires Saint-Luc)
Human Mutation
August 29, 2013
Cited by 290

Abstract

Capillary malformation-arteriovenous malformation (CM-AVM) is an autosomal-dominant disorder, caused by heterozygous RASA1 mutations, and manifesting multifocal CMs and high risk for fast-flow lesions. A limited number of patients have been reported, raising the question of the phenotypic borders. We identified new patients with a clinical diagnosis of CM-AVM, and patients with overlapping phenotypes. RASA1 was screened in 261 index patients with: CM-AVM (n = 100), common CM(s) (port-wine stain; n = 100), Sturge-Weber syndrome (n = 37), or isolated AVM(s) (n = 24). Fifty-eight distinct RASA1 mutations (43 novel) were identified in 68 index patients with CM-AVM and none in patients with other phenotypes. A novel clinical feature was identified: cutaneous zones of numerous small white pale halos with a central red spot. An additional question addressed in this study was the "second-hit" hypothesis as a pathophysiological mechanism for CM-AVM. One tissue from a patient with a germline RASA1 mutation was available. The analysis of the tissue showed loss of the wild-type RASA1 allele. In conclusion, mutations in RASA1 underscore the specific CM-AVM phenotype and the clinical diagnosis is based on identifying the characteristic CMs. The high incidence of fast-flow lesions warrants careful clinical and radiologic examination, and regular follow-up.


Related Papers

No related papers found

Powered by citation graph analysis